HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

890.643

+3.6200.41%

Number of Gainers:12

Number of Losers:5

Number of Flat:- -

PE:- -

High:895.262

Open:888.337

Low:876.647

Close:887.023

Volume:324.60M

Turnover:2.32B

Market Cap:602.71B

Float Cap:497.59B

Loading ...

Baiyunshan's Tianxin Pharmaceutical Secures NMPA Drug Registration Certificate for Irbesartan Hydrochlorothiazide Tablets

Shandong Xinhua Pharmaceutical (00719): Liu Weimin Proposed as Candidate for Executive Director Appointment

Shandong Xinhua Pharmaceutical Co - Board Proposes Liu Weimin as Executive Director

THOMSON REUTERS

Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong

JD Health International Stock Rises 2.0% in Hong Kong

Hong Kong Regulators Issue Joint Statement on Audit Opinions; Nasdaq Slides 1.25%

SIHUAN PHARM Makes Strategic Investment in Hanteng Biotech to Complete Regenerative Medical Aesthetics Industry Chain

Sihuan Pharma - Unit Completes Strategic Equity Investment in Canton Biologics

THOMSON REUTERS

Is Ping An Healthcare and Technology (SEHK:1833) A Bargain As Valuation Signals Diverge?

Simply Wall St.

GenFleet-B (02595) Spends HK$3.83 Million to Buy Back 135,000 Shares on October 8

CSPC Pharma Presents Data from Cervical Cancer Study at Gynecologic Cancer Society Meeting

MT Newswires Live

Sino Biopharma Unit Completes Patient Enrollment for Pulmonary Disease Drug Trial

MT Newswires Live

SanegeneBio Said to Weigh Hong Kong IPO Next Year After Confidential Filing

CSPC Pharma Unveils Phase I Data for SYS6002 Monotherapy in Advanced Cervical Cancer at IGCS 2026 Rapid Oral Presentation

Shandong Xinhua Pharmaceutical Gets Drug Registration Certificate for Sacubitril Valsartan Sodium Tablets

Sino Biopharmaceutical Stock Slides 3.3% in Hong Kong

CSPC Pharmaceutical Group Stock Sheds 5.4% in Hong Kong, Underperforms Competitors

Hanchuan Market Supervision Bureau Strengthens Joint Regulation Through Triple-Medical Coordination

Hong Kong Stock Market Movers: Innovative Drug Stocks Deepen Losses in Afternoon Session, Ascletis Pharma-B (01672) Falls Over 10%, Innovent Bio (01801) Drops Nearly 4%

Yahong Meditech Signs Exclusive Licensing Agreement with Theramex

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hkg.itiger.com/stock/BK1515/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":890.6432,"timestamp":1791533285939,"preClose":887.02344,"halted":0,"volume":324597422,"delay":0,"changeRate":0.004081,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":3.619751,"latestTime":"10-09 16:00:00","open":888.33716,"high":895.2623,"low":876.64734,"amount":2321538546,"amplitude":0.020986,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"pbRate":1.356136,"peRate":17.574274,"turnoverRate":0.004258,"increases":10,"decrements":5,"flats":2,"marketCap":602711365184,"floatMarketCap":497586442560},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":895.2623,"amplitude":0.020986,"preClose":887.02344,"low":876.64734,"pbRate":"1.356136","latestPrice":890.6432,"volume":324597422,"delay":0,"open":888.33716,"prevYearClose":1190.107,"prevWeekClose":903.801,"prevMonthClose":925.469,"prevQuarterClose":925.469,"fiveDayClose":903.801,"twentyDayClose":890.408,"sixtyDayClose":938.528,"secType":"PLATE","market":"HK","turnoverRate":0.004258,"peRate":17.574274,"marketCap":602711365184,"floatMarketCap":497586442560,"timestamp":1791533285939,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":12,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188530342","title":"Baiyunshan's Tianxin Pharmaceutical Secures NMPA Drug Registration Certificate for Irbesartan Hydrochlorothiazide Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1188530342","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188530342?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:00","pubTimestamp":1791540015,"startTime":"0","endTime":"0","summary":"Baiyunshan (ASX: 00874) has announced that its controlling subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (\"Tianxin Pharmaceutical\"), recently received a Drug Registration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","01477","BK0196","BK1574","BK0096","BK0028","BK1515","BK1191","BK0012","BK1606","BK0175","600332","BK1521","BK0183","BK0070","BK0239","BK1197","00874","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161581394","title":"Shandong Xinhua Pharmaceutical (00719): Liu Weimin Proposed as Candidate for Executive Director Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1161581394","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161581394?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:40","pubTimestamp":1791538813,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical (00719) has issued an announcement stating that the Board of Directors has resolved to propose Mr. Liu Weimin (Mr. Liu) as a candidate for appointment as an executive...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674309468","title":"Shandong Xinhua Pharmaceutical Co - Board Proposes Liu Weimin as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2674309468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674309468?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:37","pubTimestamp":1791538651,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nFWN45V12W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK0164","BK0239","00719","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674328258","title":"Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2674328258","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674328258?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:33","pubTimestamp":1791534780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 5.41 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.8% to 24211.35.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 33% short of its 52-week high of HK$8.08, which the company reached Oct. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 2.2% and Amgen Inc. remained unchanged.Trading volume totaled 72.7 million shares, compared to the 50-day average of 80.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BK4533","HK0000165453.HKD","BK4585","LU1061106388.HKD","LU1023059063.AUD","LU2089984988.USD","BK4599","IE00B2B36J28.USD","BK1589","IE00BJT1NW94.SGD","LU0109394709.USD","LU2112291526.USD","IBB","LU0889565916.HKD","IE0002141913.USD","IE00BZ08YS42.EUR","LU0320765992.SGD","BK4588","LU1057294990.SGD","LU2242652126.USD","AMGN","BK4534","LU0868494617.USD","LU0122379950.USD","LU2242646821.SGD","TBXU","LU0058720904.USD","BK1191","IE00BFTCPJ56.SGD","BIB","BK1521","IE0009355771.USD","LU1983299246.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","PBE","SG9999001440.SGD","BK4139","IBBQ","BK1515","IE00BJJMRZ35.SGD","LU0289739699.SGD","BK4566","LU1571399168.USD","PJP","BK4581","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674303832","title":"JD Health International Stock Rises 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2674303832","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674303832?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:33","pubTimestamp":1791534780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. rose 2.0% to 36.08 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.8% to 24211.35.This was the stock's fifth consecutive day of gains.JD Health International Inc. closed 50% below its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 5.0 million shares, compared to the 50-day average of 8.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ62798434.SGD","BK1515","BK1615","SGXZ86797644.SGD","BK1571","86618","LU0051755006.USD","BK1589","LU0456827905.SGD","BK1591","BK1247","06618","BK1142","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114675251","title":"Hong Kong Regulators Issue Joint Statement on Audit Opinions; Nasdaq Slides 1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114675251","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114675251?lang=en_us&edition=fundamental","pubTime":"2026-10-09 08:02","pubTimestamp":1791504126,"startTime":"0","endTime":"0","summary":"Hong Kong's Securities and Futures Commission, the Accounting and Financial Reporting Council, and the Stock Exchange of Hong Kong have issued a joint statement addressing growing regulatory concerns...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1238","IE00BZ08YS42.EUR","LU0516422440.USD","LU0149721374.USD","LU0516423091.SGD","BK1109","02026","LU1481107354.HKD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1589","SG9999001093.SGD","BK1502","LU0163747925.USD","BK1511","BK1593","BK1191","01177","BK1515","BK1129","06887","IXIC","LU0871576103.HKD","BK1600","80883","LU0039217434.USD","FRCOY","BK1528","HK0000165453.HKD","BK1181","BK1594","LU1242518857.USD","LU0531971595.HKD","SBHMY","06055","LU0164880469.USD","LU1064130708.USD","00883","600938","00460","01748","BK1114","LU0516422952.EUR","LU0516423174.USD","06288","LU1242518931.SGD","LU0979878070.USD","LU1064131003.USD","00189","BK1103","LU0228367735.SGD","BK1580","PONY","BK1521","BK1522","BK1610","LU0164865239.USD","LU2148510915.USD","LU0516422366.SGD","BK1213","02720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177960521","title":"SIHUAN PHARM Makes Strategic Investment in Hanteng Biotech to Complete Regenerative Medical Aesthetics Industry Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=1177960521","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177960521?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:56","pubTimestamp":1791464176,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has announced that its subsidiary Meiyan Space Biotechnology (Jilin) Co., Ltd. (Meiyan Space) has completed a strategic equity investment in Guangzhou Hanteng Biotechnology Co.,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1515","BK1593","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673635077","title":"Sihuan Pharma - Unit Completes Strategic Equity Investment in Canton Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2673635077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673635077?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:42","pubTimestamp":1791463373,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nFWN45U1S7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1191","BK1593","BK1515","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003676","title":"Is Ping An Healthcare and Technology (SEHK:1833) A Bargain As Valuation Signals Diverge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003676","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673003676?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:32","pubTimestamp":1791462764,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology (SEHK:1833) has drawn fresh attention after recent share performance, with the stock down 8% over the past month and about 21% over the past 3 months.\nAt a share price of HK$5.96, Ping An Healthcare and Technology has not only slipped over the past month, it has also seen its 1-year total shareholder return decline 66.12%, which signals fading momentum as investors reassess both growth prospects and risk.\nCompare Ping An Healthcare and Technology's slide with...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-a-bargain-as-v","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-a-bargain-as-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1571","BK1615","LU0128526141.USD","LABU","XLV","BK1515","BK4581","BK1219","BK1142","BK4137","BK4585","BK4588","BK1247","BK1617","01833","HCSG","XBI","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186524088","title":"GenFleet-B (02595) Spends HK$3.83 Million to Buy Back 135,000 Shares on October 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1186524088","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186524088?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:48","pubTimestamp":1791460092,"startTime":"0","endTime":"0","summary":"GenFleet-B (02595) announced that on October 8, 2026, it spent HK$3.8307 million to repurchase 135,000 shares.The company disclosed the share repurchase in a filing.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595","BK1515","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673907195","title":"CSPC Pharma Presents Data from Cervical Cancer Study at Gynecologic Cancer Society Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2673907195","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673907195?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:30","pubTimestamp":1791459000,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  presented data from a phase I clinical study of SYS6002 as a rapid oral presentation at the 2026 Annual Global Meeting of the International Gynecologic Cancer Society.The trial testing the drug as monotherapy for the treatment of advanced cervical cancer found it to have a manageable safety profile and preliminary efficacy, a Thursday bourse filing showed.The drug is currently being studied for the treatment of advanced cervical cancer previously treated with immunotherapy in a phase III trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B031HY20.USD","LU0067412154.USD","KURE","LU0880133367.SGD","LU1951186391.HKD","LU1807302812.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","BK1191","IE0008369823.USD","LU1008478684.HKD","LU1328277881.USD","IE0008368742.USD","BK1515","LU0326950275.SGD","LU1226287529.USD","LU0072913022.USD","LU1960683339.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1226288170.HKD","LU0314109678.HKD","LU0501845795.SGD","LU0315179316.USD","LU1226287792.SGD","LU1226288253.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU1226287875.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1152091168.USD","01093","LU1813983027.USD","BK1521","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673165079","title":"Sino Biopharma Unit Completes Patient Enrollment for Pulmonary Disease Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673165079","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673165079?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:04","pubTimestamp":1791457490,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  said the enrollment of all subjects for a phase III clinical trial of TQC3721 inhalation suspension has been completed.The drug was developed by unit Chia Tai Tianqing Pharmaceutical Group for the maintenance treatment of chronic obstructive pulmonary disease, a Thursday bourse filing showed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1589","01177","BK1191","HK0000165453.HKD","BK1521","IE00BZ08YT58.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119194076","title":"SanegeneBio Said to Weigh Hong Kong IPO Next Year After Confidential Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=1119194076","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119194076?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:58","pubTimestamp":1791457133,"startTime":"0","endTime":"0","summary":"SanegeneBio has reportedly submitted a listing application to the Hong Kong Stock Exchange on a confidential basis, with the goal of raising several hundred million US dollars through an IPO next...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","BK1521","BK1191","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1589","HK0000165453.HKD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165903998","title":"CSPC Pharma Unveils Phase I Data for SYS6002 Monotherapy in Advanced Cervical Cancer at IGCS 2026 Rapid Oral Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1165903998","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165903998?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:28","pubTimestamp":1791455310,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the company presented Phase I clinical trial data for SYS6002 monotherapy in the treatment of advanced cervical cancer as a rapid oral presentation at the 2026...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1152091168.USD","01093","LU0140636845.USD","LU1226287792.SGD","LU1813983027.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","HK0000165453.HKD","LU0072913022.USD","IE00BZ08YS42.EUR","LU1226287529.USD","LU0315179316.USD","LU1328277881.USD","BK1515","LU0880133367.SGD","IE00B5MMRT66.SGD","LU1226288170.HKD","IE0008368742.USD","IE0008369823.USD","LU1226288253.USD","LU1993786604.SGD","LU0501845795.SGD","IE00B031HY20.USD","LU0067412154.USD","KURE","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU1960683339.HKD","LU0326950275.SGD","LU1152091754.HKD","SG9999004220.SGD","LU1008478684.HKD","LU2039709279.SGD","BK1191","BK1521","LU1951186391.HKD","LU1226287875.USD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184199481","title":"Shandong Xinhua Pharmaceutical Gets Drug Registration Certificate for Sacubitril Valsartan Sodium Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1184199481","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184199481?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:56","pubTimestamp":1791449785,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical (00719) has announced that the company recently received the Drug Registration Certificate for Sacubitril Valsartan Sodium Tablets approved and issued by the National...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022200","title":"Sino Biopharmaceutical Stock Slides 3.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022200","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022200?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:32","pubTimestamp":1791448320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 3.3% to 5.49 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.4% to 23785.79.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 35% below its 52-week high of HK$8.48, which the company reached Oct. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 5.4% and Amgen Inc. remained unchanged.Trading volume totaled 82.2 million shares, compared to the 50-day average of 79.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","BK4533","IE00B4R5TH58.HKD","IBB","LU1061106388.HKD","IE00BZ08YR35.GBP","LU0109394709.USD","LU0868494617.USD","BK4566","LU1571399168.USD","BK4599","LU0320765992.SGD","IE00BZ08YS42.EUR","BK4581","BK1589","01177","TBXU","BK1191","LU0889565916.HKD","IE00BJJMRZ35.SGD","BK1521","LU2112291526.USD","IE0002141913.USD","PBE","HK0000165453.HKD","BK4534","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4585","IE0009355771.USD","IE00BZ08YT58.USD","BK4139","LU1983299246.USD","LU1057294990.SGD","AMGN","PJP","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","BK1515","LU0058720904.USD","LU1023059063.AUD","BBH","BK4588","IE00B2B36J28.USD","LU2242646821.SGD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022424","title":"CSPC Pharmaceutical Group Stock Sheds 5.4% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022424","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022424?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:31","pubTimestamp":1791448260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 5.4% to 9.29 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.4% to 23785.79.This was the stock's second consecutive day of losses.CSPC Pharmaceutical Group Ltd. closed 15% short of its 52-week high of HK$10.96, which the company reached Jan. 30.The stock underperformed when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 3.3%, SSY Group Ltd. rose 1.3%, and United Laboratories International Holdings Ltd. fell 1.3%.Trading volume totaled 92.2 million shares, compared to the 50-day average of 90.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328277881.USD","IE0008368742.USD","IE00B031HY20.USD","LU1813983027.USD","LU1993786604.SGD","LU0501845795.SGD","LU0067412154.USD","LU1226288253.USD","IE0008369823.USD","IE00B543WZ88.USD","LU1226287875.USD","LU0140636845.USD","LU2039709279.SGD","LU1008478684.HKD","SG9999004220.SGD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","HK0000165453.HKD","BK1191","LU0072913022.USD","LU0315179316.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","LU1951186391.HKD","IE00BZ08YS42.EUR","LU0314109678.HKD","01093","KURE","LU1226287529.USD","91335","LU1152091754.HKD","LU1226288170.HKD","BK1521","LU0880133367.SGD","BK1515","LU1152091168.USD","LU1807302812.USD","LU0326950275.SGD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114120397","title":"Hanchuan Market Supervision Bureau Strengthens Joint Regulation Through Triple-Medical Coordination","url":"https://stock-news.laohu8.com/highlight/detail?id=1114120397","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114120397?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:30","pubTimestamp":1791448257,"startTime":"0","endTime":"0","summary":"According to an October 2 statement from the main official of the Hanchuan City Market Supervision Bureau in Hubei Province, the bureau has further improved its long-term regulatory mechanism for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165973977","title":"Hong Kong Stock Market Movers: Innovative Drug Stocks Deepen Losses in Afternoon Session, Ascletis Pharma-B (01672) Falls Over 10%, Innovent Bio (01801) Drops Nearly 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165973977","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165973977?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:08","pubTimestamp":1791439696,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, losses among innovative drug concept stocks widened in the afternoon session. As of press time, Ascletis Pharma-B (01672) fell 9.82% to HK$7.62; InnoCare (09969)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU2097828805.USD","01801","IBBQ","LU0244354667.USD","01477","LU0607220059.USD","HK0000165453.HKD","BK1515","LU2097828557.USD","BK1589","VXUS","LU2328871848.SGD","01672","LU0463099449.HKD","LU1969619763.USD","LU2097828631.EUR","LU2488822045.USD","LU0455707207.USD","LU0149534421.HKD","BK1191","LU1831875114.USD","KCAI","BK1583","KURE","09969","MEDX","BK1161","BK4585","LU0502904849.HKD","LU2097828474.EUR","159992","LU1188198961.HKD","06978","BK1593","BK4588","LU2097828714.EUR","LNGR","01530","BK1574","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100819819","title":"Yahong Meditech Signs Exclusive Licensing Agreement with Theramex","url":"https://stock-news.laohu8.com/highlight/detail?id=1100819819","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100819819?lang=en_us&edition=fundamental","pubTime":"2026-10-07 15:46","pubTimestamp":1791359174,"startTime":"0","endTime":"0","summary":"Yahong Meditech (688176.SH) has announced that it recently entered into a conditional Exclusive Licensing Agreement with Theramex HQ UK Limited (\"Theramex\").Under the licensing agreement, Theramex...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK0239","159938","BK1515","688176","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":113,"code":"91000000","status":"200"}]}}